Cargando…

PET/CT in the evaluation of anti-NMDA-receptor encephalitis: What we need to know as a NM physician

Anti N-methyl-D-aspartate receptor encephalitis (ANMDARE), also known as limbic encephalitis (LE), is a treatable rare disorder characterized by personality changes, irritability, depression, seizures, memory loss and sometimes dementia. It is classified under paraneoplastic syndrome (PNS) and produ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padma, S, Sundaram, P Shanmuga, Marmattom, Bobby Varkey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237228/ https://www.ncbi.nlm.nih.gov/pubmed/22174517 http://dx.doi.org/10.4103/0972-3919.90262

Ejemplares similares

Role of FDG PET/CT in Baastrup's disease
por: Subramanyam, Padma, et al.
Publicado: (2016)

PET/CT in paediatric malignancies - An update
por: Padma, Subramanyam, et al.
Publicado: (2016)

PET/CT imaging: what radiologists need to know
por: Benamor, M., et al.
Publicado: (2007)

Dual Time Point (18)F-FDG PET/CT Imaging Identifies Bilateral Renal Tuberculosis in an Immunocompromised Patient with an Unknown Primary Malignancy
por: Subramanyam, Padma, et al.
Publicado: (2015)

Epigenetics in Schistosomes: What We Know and What We Need Know
por: Liu, Weiwei
Publicado: (2016)

Portion Size: What We Know and What We Need to Know
por: Benton, David
Publicado: (2015)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

Metabolic syndrome: what we know and what we need to know
por: Soares, Raquel
Publicado: (2020)

Atypical Presentation of Marginal Zone Lymphoma as Isolated Diffuse Bone Marrow Involvement: Utility of F-18 FDG PET/CT in Diagnosis and Response Assessment
por: Gauthaman, Dinesh Kumar, et al.
Publicado: (2022)

Big Tau: What We Know, and We Need to Know
por: Fischer, Itzhak
Publicado: (2023)

Decreased occipital lobe metabolism by FDG-PET/CT: An anti–NMDA receptor encephalitis biomarker
por: Probasco, John C., et al.
Publicado: (2017)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

Nephrotoxicity testing in vitro--what we know and what we need to know.
por: Pfaller, W, et al.
Publicado: (1998)

Goal-directed therapy: what we know and what we need to know
por: O’Neal, Jason B, et al.
Publicado: (2015)

Membrane fission by dynamin: what we know and what we need to know
por: Antonny, Bruno, et al.
Publicado: (2016)

Microplastics in freshwater ecosystems: what we know and what we need to know
por: Wagner, Martin, et al.
Publicado: (2014)

Peri-implant disease: what we know and what we need to know
por: Valente, Nicola Alberto, et al.
Publicado: (2016)

Pneumonia in Bhutanese children: what we know, and what we need to know
por: Jullien, Sophie, et al.
Publicado: (2020)

Impacts of Neonicotinoids on Molluscs: What We Know and What We Need to Know
por: Ewere, Endurance E, et al.
Publicado: (2021)

Pregnant adolescents living with HIV: what we know, what we need to know, where we need to go
por: Callahan, Tegan, et al.
Publicado: (2017)

Online Social Capital and Health What: We Know, What We Need to Know
por: Kwon, Youngbum
Publicado: (2021)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Olfaction and COVID: The little we Know and what else we need to know
por: Pinna, Fábio de Rezende, et al.
Publicado: (2020)

Induction of Asthma and the Environment: What We Know and Need to Know
por: Selgrade, MaryJane K., et al.
Publicado: (2006)

Secondary electron yield of surfaces: what we know and what we still need to know
por: Taborelli, M
Publicado: (2020)

Exercise and Alcohol Consumption: What We Know, What We Need to Know, and Why it is Important
por: Leasure, J. Leigh, et al.
Publicado: (2015)

A Decade of Mighty Lipophagy: What We Know and What Facts We Need to Know?
por: Khawar, Muhammad Babar, et al.
Publicado: (2021)

Abdominal distension following radical cystectomy: what we know and what we need to know
por: Hanna, Peter
Publicado: (2022)

Plant virus metagenomics: what we know and why we need to know more
por: Stobbe, Anthony H., et al.
Publicado: (2014)

Alveolar epithelial and endothelial cell apoptosis in emphysema: What we know and what we need to know
por: Morissette, Mathieu C, et al.
Publicado: (2009)

High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know
por: Üçeyler, Nurcan, et al.
Publicado: (2014)

From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia
por: Cariaga-Martinez, Ariel, et al.
Publicado: (2016)

Editorial: Anomalous aortic origin of coronary arteries: What we know, what we need to know
por: Fujii, Kenichi, et al.
Publicado: (2015)

COVID-19—What we know and what we need to know: There are more questions than answers
por: Maisch, Bernhard, et al.
Publicado: (2020)

What we know and what we need to know about the origin of SARS-CoV-2
por: Domingo, Jose L.
Publicado: (2021)

Host-Viral Interactions at the Maternal-Fetal Interface. What We Know and What We Need to Know
por: Girsch, James H., et al.
Publicado: (2022)

Precision Radiotherapy: (18)F-FDG PET-based radiotherapy planning in Head and Neck cancers
por: Subramanyam, Padma, et al.
Publicado: (2020)

Hypertensive disorders of pregnancy: what the physician needs to know
por: Anthony, John, et al.
Publicado: (2016)

Physician-Assisted Death: What Everyone Needs to Know
por: Wickline, Mary A.
Publicado: (2018)

Antibiotics and Liver Cirrhosis: What the Physicians Need to Know
por: Zoratti, Caterina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ha68aemuinta7nflf1u3grdttc